|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 535.67 USD | +1.25% |
|
-2.08% | +9.94% |
| 15/07 | United Therapeutics Insider Sold Shares Worth $5,091,949, According to a Recent SEC Filing | MT |
| 14/07 | United Therapeutics Insider Sold Shares Worth $5,173,660, According to a Recent SEC Filing | MT |
| Market Cap | 2.27TCr 1.99TCr 1.83TCr 1.69TCr 3.19TCr 2,19000Cr 3.26TCr 22TCr 8.62TCr 1,07200Cr 8.54TCr 8.35TCr 3,69200Cr | P/E 2026 * |
20x | P/E 2027 * | 17x |
|---|---|---|---|---|---|
| Enterprise Value | 2.01TCr 1.76TCr 1.62TCr 1.49TCr 2.81TCr 1,93500Cr 2.88TCr 19TCr 7.62TCr 95TCr 7.55TCr 7.38TCr 3,26200Cr | EV / Sales 2026 * |
6.21x | EV / Sales 2027 * | 5.12x |
| Free-Float |
53.7% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: United Therapeutics Corporation
| 1 day | +1.25% | ||
| 1 week | -2.08% | ||
| Current month | -1.14% | ||
| 1 month | -0.17% | ||
| 3 months | -8.96% | ||
| 6 months | +15.22% | ||
| Current year | +9.94% |
| 1 week | 520.05 |  | 543.56 |
| 1 month | 520.05 | | 563.7 |
| Current year | 455.63 | | 609.35 |
| 1 year | 272.12 | | 609.35 |
| 3 years | 208.62 | | 609.35 |
| 5 years | 158.38 | | 609.35 |
| 10 years | 74.31 | | 609.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 71 | 26/06/1996 | |
| President | 54 | 26/06/2016 | |
James Edgemond
DFI | Director of Finance/CFO | 58 | 13/03/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Raymond Kurzweil
BRD | Director/Board Member | 78 | 01/01/2002 |
| Chairman | 71 | 26/06/1996 | |
Louis Sullivan
BRD | Director/Board Member | 92 | 01/01/2002 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 16/07/26 | Fiscal year | General Counsel | 24,900 | 0.0587% | ||
| 15/07/26 | Fiscal year | Chief Executive Officer | 28,500 | 0.0671% | ||
| 14/07/26 | Fiscal year | Chief Executive Officer | 28,500 | 0.0671% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.25% | -2.08% | +83.44% | +125.16% | 2.27TCr | |
| +0.85% | -0.80% | +52.79% | +161.33% | 1,05100Cr | |
| +1.23% | -1.53% | +54.58% | +59.08% | 61TCr | |
| +0.04% | +2.58% | +34.47% | +86.33% | 45TCr | |
| +0.78% | -0.71% | +29.28% | +24.10% | 33TCr | |
| +1.41% | +0.58% | +35.44% | +40.67% | 28TCr | |
| -0.27% | -1.87% | +22.34% | +22.51% | 26TCr | |
| -1.76% | +2.37% | -20.43% | -38.00% | 22TCr | |
| -1.42% | +0.80% | +24.27% | +57.50% | 20TCr | |
| -1.48% | +3.43% | +24.08% | +71.67% | 17TCr | |
| Average | +0.06% | +0.28% | +34.03% | +61.03% | 35.98TCr | |
| Weighted average by Cap. | +0.38% | +0.01% | +37.80% | +79.92% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 323.55Cr 282.75Cr 260.92Cr 240.5Cr 453.3Cr 31TCr 463.36Cr 3.12TCr 1.23TCr 15TCr 1.22TCr 1.19TCr 53TCr | 368.59Cr 322.11Cr 297.23Cr 273.97Cr 516.39Cr 35TCr 527.85Cr 3.55TCr 1.4TCr 17TCr 1.38TCr 1.35TCr 60TCr |
| Net income | 124.21Cr 108.55Cr 100.16Cr 92Cr 174.02Cr 12TCr 177.88Cr 1.2TCr 470.89Cr 5.86TCr 466.47Cr 456.24Cr 20TCr | 147.5Cr 128.9Cr 118.95Cr 109.64Cr 206.65Cr 14TCr 211.23Cr 1.42TCr 559.19Cr 6.96TCr 553.93Cr 541.78Cr 24TCr |
| Net Debt | -264.59Cr -231.22Cr -213.37Cr -196.67Cr -370.69Cr -25TCr -378.91Cr -2.55TCr -1TCr -12TCr -993.65Cr -971.85Cr -43TCr | -386.38Cr -337.66Cr -311.58Cr -287.2Cr -541.32Cr -37TCr -553.33Cr -3.72TCr -1.46TCr -18TCr -1.45TCr -1.42TCr -63TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | $535.67 | +1.25% | 4,22,243 |
| 16/26/16 | $529.05 | -0.52% | 3,50,858 |
| 15/26/15 | $531.79 | +0.97% | 4,48,059 |
| 14/26/14 | $526.66 | -1.66% | 3,72,647 |
| 13/26/13 | $535.57 | -2.10% | 3,03,818 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- UTHR Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition